Verition Fund Management LLC Agios Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $230,344 - $322,801	-6,936 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $234,922 - $387,930	6,936 New	6,936 $243,000
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $152,178 - $259,794	-4,828 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $52,760 - $88,734	-1,754 Reduced 26.65%	4,828 $231,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $213,256 - $326,335	6,582 New	6,582 $213,000
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $418,992 - $618,007	-9,075 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $416,724 - $614,105	9,075 New	9,075 $612,000
Q2 2018 Aug 15, 2018	SELL	$73.22 - $99.55 $602,454 - $819,097	-8,228 Closed	0 $0
Q1 2018 May 16, 2018	BUY	$59.83 - $86.53 $492,281 - $711,968	8,228 New	8,228 $673,000
Q4 2017 Feb 15, 2018	SELL	$52.12 - $72.33 $409,194 - $567,862	-7,851 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $430,941 - $526,959	7,851	7,851 $524,000

226

56.3M

275K

251K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.5B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.